“Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group”. - Moore,M.; Goldstein,D. (J Clin Oncol, 2007)